Latin America Sterile Injectables Cdmo Market Size & Outlook

The sterile injectables cdmo market in Latin America is expected to reach a projected revenue of US$ 610.9 million by 2030. A compound annual growth rate of 9.5% is expected of Latin America sterile injectables cdmo market from 2024 to 2030.
Revenue, 2023 (US$M)
$324.5
Forecast, 2030 (US$M)
$610.9
CAGR, 2024 - 2030
9.5%
Report Coverage
Latin America

Latin America sterile injectables cdmo market, 2018-2030 (US$M)

Latin

Latin America sterile injectables cdmo market highlights

  • The Latin America sterile injectables cdmo market generated a revenue of USD 324.5 million in 2023.
  • The market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
  • In terms of segment, small molecule was the largest revenue generating molecule type in 2023.
  • Small Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Latin America data book summary

Market revenue in 2023USD 324.5 million
Market revenue in 2030USD 610.9 million
Growth rate9.5% (CAGR from 2023 to 2030)
Largest segmentSmall molecule
Fastest growing segmentSmall Molecule
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule
Key market players worldwideBoehringer Ingelheim, Baxter International Inc, Vetter Pharma-Fertigung, Recipharm, Fresenius Kabi, Ajinomoto, PCI Pharma Services, IDT Biologika, Alcami, Fareva, Eurofins Scientific SE, Siegfried Holding AG


Other key industry trends

  • In terms of revenue, Latin America region accounted for 8.2% of the global sterile injectables cdmo market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,079.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sterile Injectables CDMO Market Scope

Sterile injectables cdmo market segmentation & scope
Small Molecule
Large Molecule
Product
Sterile Liquid Injectables
Pre-filled Syringes
Vials and Ampoules
Service
Contract Development
Contract Manufacturing
Packaging
Quality Control and Assurance
Lyophilization Services
Therapeutic Area
Oncology
Cardiovascular Diseases
Central Nervous System Diseases
Infectious Disorders
Musculoskeletal Diseases
Hormonal Diseases
Others
Administration
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
End Use
Pharmaceutical Companies
Biopharmaceutical Companies
Others
Countries
U.S.
Canada
Mexico
Denmark
France
Germany
Italy
Norway
Spain
Sweden
UK
Australia
China
India
Japan
South Korea
Thailand
Brazil
Argentina
UAE
South Africa
Saudi Arabia
Kuwait

Sterile Injectables CDMO Market Companies

Name Profile # Employees HQ Website

Latin America sterile injectables cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectables cdmo market will help companies and investors design strategic landscapes.


Small molecule was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America sterile injectables cdmo market based on small molecule covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Latin America sterile injectables cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America sterile injectables cdmo market databook

  • Our clientele includes a mix of sterile injectables cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America sterile injectables cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America sterile injectables cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America sterile injectables cdmo market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more